Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALKEM LABORATORIES vs SEQUENT SCIENTIFIC - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALKEM LABORATORIES SEQUENT SCIENTIFIC ALKEM LABORATORIES/
SEQUENT SCIENTIFIC
 
P/E (TTM) x 31.0 175.4 17.7% View Chart
P/BV x 6.5 8.3 78.6% View Chart
Dividend Yield % 0.7 0.0 -  

Financials

 ALKEM LABORATORIES   SEQUENT SCIENTIFIC
EQUITY SHARE DATA
    ALKEM LABORATORIES
Mar-24
SEQUENT SCIENTIFIC
Mar-24
ALKEM LABORATORIES/
SEQUENT SCIENTIFIC
5-Yr Chart
Click to enlarge
High Rs5,519155 3,550.4%   
Low Rs3,21170 4,601.7%   
Sales per share (Unadj.) Rs1,059.454.9 1,929.2%  
Earnings per share (Unadj.) Rs151.5-1.2 -12,760.7%  
Cash flow per share (Unadj.) Rs176.51.3 13,791.4%  
Dividends per share (Unadj.) Rs40.000-  
Avg Dividend yield %0.90-  
Book value per share (Unadj.) Rs860.823.2 3,706.6%  
Shares outstanding (eoy) m119.57249.43 47.9%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x4.12.1 200.9%   
Avg P/E ratio x28.8-94.9 -30.4%  
P/CF ratio (eoy) x24.788.0 28.1%  
Price / Book Value ratio x5.14.8 104.6%  
Dividend payout %26.40-   
Avg Mkt Cap Rs m521,91028,090 1,858.0%   
No. of employees `000NANA-   
Total wages/salary Rs m22,0102,506 878.4%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m126,67613,697 924.8%  
Other income Rs m3,108110 2,836.9%   
Total revenues Rs m129,78413,807 940.0%   
Gross profit Rs m21,240440 4,824.8%  
Depreciation Rs m2,993615 486.4%   
Interest Rs m1,124481 233.8%   
Profit before tax Rs m20,231-546 -3,702.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,117-250 -845.6%   
Profit after tax Rs m18,115-296 -6,117.1%  
Gross profit margin %16.83.2 521.7%  
Effective tax rate %10.545.8 22.8%   
Net profit margin %14.3-2.2 -661.4%  
BALANCE SHEET DATA
Current assets Rs m104,1168,109 1,283.9%   
Current liabilities Rs m39,9466,270 637.1%   
Net working cap to sales %50.713.4 377.2%  
Current ratio x2.61.3 201.5%  
Inventory Days Days229 244.3%  
Debtors Days Days6589 72.6%  
Net fixed assets Rs m36,4856,392 570.8%   
Share capital Rs m239499 47.9%   
"Free" reserves Rs m102,6865,294 1,939.8%   
Net worth Rs m102,9255,793 1,776.9%   
Long term debt Rs m4001,427 28.0%   
Total assets Rs m140,60114,620 961.7%  
Interest coverage x19.0-0.1 -13,925.7%   
Debt to equity ratio x00.2 1.6%  
Sales to assets ratio x0.90.9 96.2%   
Return on assets %13.71.3 1,082.9%  
Return on equity %17.6-5.1 -344.3%  
Return on capital %20.7-0.9 -2,274.7%  
Exports to sales %16.01.4 1,168.5%   
Imports to sales %00.6 0.0%   
Exports (fob) Rs m20,316188 10,806.4%   
Imports (cif) Rs mNA81 0.0%   
Fx inflow Rs m20,316188 10,806.4%   
Fx outflow Rs m5,41381 6,682.6%   
Net fx Rs m14,903107 13,928.1%   
CASH FLOW
From Operations Rs m19,481306 6,367.3%  
From Investments Rs m-10,085-59 17,035.5%  
From Financial Activity Rs m-11,450-14 79,569.8%  
Net Cashflow Rs m-2,075232 -893.0%  

Share Holding

Indian Promoters % 55.7 0.0 -  
Foreign collaborators % 0.0 52.8 -  
Indian inst/Mut Fund % 28.2 16.4 171.7%  
FIIs % 9.0 6.5 139.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 44.3 47.2 93.9%  
Shareholders   74,744 154,603 48.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALKEM LABORATORIES With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on ALKEM LABORATORIES vs SEQUENT SCIENTIFIC

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

ALKEM LABORATORIES vs SEQUENT SCIENTIFIC Share Price Performance

Period ALKEM LABORATORIES SEQUENT SCIENTIFIC S&P BSE HEALTHCARE
1-Day 1.41% -1.56% 0.11%
1-Month -9.00% 1.86% -3.22%
1-Year 24.79% 77.18% 42.65%
3-Year CAGR 19.48% 3.68% 19.86%
5-Year CAGR 21.75% 23.95% 25.90%

* Compound Annual Growth Rate

Here are more details on the ALKEM LABORATORIES share price and the SEQUENT SCIENTIFIC share price.

Moving on to shareholding structures...

The promoters of ALKEM LABORATORIES hold a 55.7% stake in the company. In case of SEQUENT SCIENTIFIC the stake stands at 52.8%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of ALKEM LABORATORIES and the shareholding pattern of SEQUENT SCIENTIFIC.

Finally, a word on dividends...

In the most recent financial year, ALKEM LABORATORIES paid a dividend of Rs 40.0 per share. This amounted to a Dividend Payout ratio of 26.4%.

SEQUENT SCIENTIFIC paid Rs 0.0, and its dividend payout ratio stood at -0.0%.

You may visit here to review the dividend history of ALKEM LABORATORIES, and the dividend history of SEQUENT SCIENTIFIC.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Indian Rupee at Record Low | Belrise Industries IPO | Top Buzzing Stocks Today Indian Rupee at Record Low | Belrise Industries IPO | Top Buzzing Stocks Today(Pre-Open)

On Thursday, Indian share markets traded lower throughout the trading session and ended on a weak note.